Article Information
History
- January 5, 2024.
Article Versions
- Version 1 (January 18, 2022 - 20:51).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei province, China. 430071
- 2Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China. 430071
- 3Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Wuhan 430071, China
- 4Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
- ↵#Correspondence:
Xiaoping Liu, Department of Pathology, Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China. 430071; Email: liuxiaoping{at}whu.edu.cn Xinghuan Wang, Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, Hubei province, China. 430071. Email: wangxinghuan{at}whu.edu.cn Sheng Li, Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center; Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Email: lisheng-znyy{at}whu.edu.cn
Posted January 05, 2024.
CBioProfiler: a web and standalone pipeline for cancer biomarker and subtype characterization
